Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.39 |
| ▸ | HIPK4 | Q8NE63 | 2/20 | 0.39 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.38 |
| ▸ | FZD7 | O75084 | 1/20 | 0.38 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.37 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.37 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | DGAT1 | O75907 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6337259 | 0.94 | HIPK4 (0.40) | MAPTLMNATP53HIPK4HCRTR1 | |
| SCHEMBL6332861 | 0.92 | TRPV1 (0.42) | MAPTLMNATP53MEN1KMT2A | |
| SCHEMBL6329843 | 0.90 | MAPT (0.41) | MAPTLMNATP53MEN1KMT2A | |
| SCHEMBL6325625 | 0.90 | MAPT (0.45) | MAPTLMNATP53MEN1KMT2A | |
| SCHEMBL6334763 | 0.86 | MAPT (0.38) | MAPTLMNATP53MEN1CYP2C9 | |
| SCHEMBL6327463 | 0.86 | PPARA (0.42) | MAPTMEN1KMT2ASLC22A12PPARA | |
| Trifluoroacetic Acid SCHEMBL6334767 | 0.85 | DGAT1 (0.47) | MAPTHCRTR1MEN1CYP1A2KMT2A | |
| SCHEMBL6326632 | 0.84 | MAPT (0.39) | MAPTLMNATP53SLC22A12PPARG | |
| SCHEMBL6327695 | 0.84 | TP53 (0.43) | MAPTLMNATP53MEN1KMT2A | |
| SCHEMBL6329108 | 0.83 | HIPK4 (0.40) | MAPTLMNATP53HIPK4CXCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050014805-A1 | Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity | BAYER PHARMACEUTICALS CORPORATION | 2005-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014805-A1 | Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity | GPR119, EGLN3, PC | MAPT 3022/4885LMNA 2130/4885TP53 2790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.